関連する実験動画
Updated: May 11, 2026

08:59
Defining Substrate Specificities for Lipase and Phospholipase Candidates
Published on: November 23, 2016
アイソフォーム特異的阻害剤を用いて,脂質キナーゼを標的とする
1Clinical Research and Human Biology Divisions, Fred Hutchinson Cancer Research Center, D2-100, 1100 Fairview Avenue North, Seattle, WA 98109, USA. jsimon@fhcrc.org
Cell
|May 23, 2006
まとめ
小分子阻害剤は,フォスホイノシチド3キナーゼ (PI3-K) の同型であるp110αが,インスリンシグナル伝達に不可欠であることを明らかにします. p110alphaとmTORキナーゼの活性を阻害すると,膠原腫の成長が制限されます.
科学分野:
- バイオケミストリー バイオケミストリー
- 分子生物学は分子生物学である.
- 薬理学 薬理学とは
背景:
- フォスフォノシチド3キナーゼ (PI3-K) 信号伝達経路は,重要な細胞プロセスを調節する.
- PI3-Kシグナリングの調節不全は,がんや代謝障害を含む様々な疾患に起因しています.
- p110alphaなどのPI3-Kの特定の同型は,細胞機能において異なる役割を果たします.
研究 の 目的:
- 小分子阻害剤を用いたPI3-Kファミリーの詳細な薬理学的分析を行う.
- インスリンシグナル伝達におけるPI3-Kイソフォームの特定の役割を解明する.
- 膠原腫の成長におけるPI3-KとmTORを阻害する治療の可能性を調査する.
主な方法:
- PI3-Kファミリーの薬理学的分析のために小分子阻害剤を使用しました.
- インスリンシグナル伝達経路に対する阻害剤の影響を調査した.
- 統合されたp110alphaとmTORの阻害がグリオマ細胞増殖に与える影響を評価した.
主要な成果:
- インスリンシグナル伝達を媒介するPI3-Kの重要な同型としてp110alphaを特定した.
- p110alphaがPI3-K経路で重要な役割を果たしていることが示されました.
- p110alphaとmTORキナーゼの活性の両方を抑制することで,グリオマの成長を大幅に抑制することが示されました.
結論:
- p110alphaはインスリンシグナル伝達の重要なメディエーターである.
- 小分子阻害剤でp110alphaとmTORを標的にすることは,膠原腫に対する潜在的な治療戦略です.
- PI3-Kイソフォームの薬理学的解剖は,それらの特定の生物学的機能の洞察を提供します.
関連する概念動画
Phosphoinositides and PIPs
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Targets for Drug Action: Overview
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...

